157 related articles for article (PubMed ID: 4060809)
1. Cellular cytotoxicity against autologous hepatocytes in chronic hepatitis B--its relationship to the HBeAg/anti-HBe status.
Poralla T; Hütteroth TH; Staritz M; Meyer zum Büschenfelde KH
Z Gastroenterol; 1985 Apr; 23(4):183-7. PubMed ID: 4060809
[TBL] [Abstract][Full Text] [Related]
2. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
3. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
4. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
[TBL] [Abstract][Full Text] [Related]
6. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
Jelić D; Jelić O
Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic lymphocyte subpopulation defined by monoclonal antibodies in anti-HBe positive type B chronic active hepatitis.
Yamada G; Hyodo I; Nishihara T; Nagashima H
Gastroenterol Jpn; 1985 Oct; 20(5):441-6. PubMed ID: 4076728
[TBL] [Abstract][Full Text] [Related]
9. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
[TBL] [Abstract][Full Text] [Related]
12. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.
Imai M; Nomura M; Gotanda T; Sano T; Tachibana K; Miyamoto H; Takahashi K; Toyama S; Miyakawa Y; Mayumi M
J Immunol; 1982 Jan; 128(1):69-72. PubMed ID: 6172494
[TBL] [Abstract][Full Text] [Related]
14. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
15. [Delta infection in HBsAg carriers].
Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
[TBL] [Abstract][Full Text] [Related]
16. [Activity of guanase in serum and liver function tests in HBe antigen-positive chronic hepatitis].
Nishikawa Y; Fukumoto K; Watanabe F; Yoshihara H
Rinsho Byori; 1989 Dec; 37(12):1392-4. PubMed ID: 2614968
[TBL] [Abstract][Full Text] [Related]
17. HBeAg and anti-HBe in chronic hepatitis B virus infection.
Chen DS; Sung JL; Lai MY
Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
[No Abstract] [Full Text] [Related]
18. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.
Alexander GJ; Mondelli M; Naumov NV; Nouriaria KT; Vergani D; Lowe D; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Mar; 63(3):498-507. PubMed ID: 2940037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
